8158 Stock Overview
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
China Regenerative Medicine International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.27 |
| 52 Week High | HK$1.20 |
| 52 Week Low | HK$0.28 |
| Beta | 1.94 |
| 1 Month Change | -6.90% |
| 3 Month Change | -49.06% |
| 1 Year Change | -74.77% |
| 3 Year Change | -94.55% |
| 5 Year Change | -95.50% |
| Change since IPO | -98.07% |
Recent News & Updates
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding
Mar 05
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%
Jan 04Recent updates
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding
Mar 05China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%
Jan 04These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively
Sep 21China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet
Jun 11Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
May 22Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
Apr 13Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Sep 22Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year
Mar 16What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?
Feb 08Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares
Dec 15
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)
Nov 25Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Nov 24Shareholder Returns
| 8158 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | -3.6% | 8.1% | 3.5% |
| 1Y | -74.8% | -40.2% | -9.9% |
Return vs Industry: 8158 underperformed the Hong Kong Biotechs industry which returned -40.2% over the past year.
Return vs Market: 8158 underperformed the Hong Kong Market which returned -9.9% over the past year.
Price Volatility
| 8158 volatility | |
|---|---|
| 8158 Average Weekly Movement | 12.2% |
| Biotechs Industry Average Movement | 9.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 8158's share price has been volatile over the past 3 months.
Volatility Over Time: 8158's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 46 | Chuang Wang | www.crmi.hk |
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People’s Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015.
China Regenerative Medicine International Limited Fundamentals Summary
| 8158 fundamental statistics | |
|---|---|
| Market cap | HK$82.15m |
| Earnings (TTM) | -HK$107.70m |
| Revenue (TTM) | HK$69.49m |
1.2x
P/S Ratio-0.8x
P/E RatioIs 8158 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8158 income statement (TTM) | |
|---|---|
| Revenue | HK$69.49m |
| Cost of Revenue | HK$50.06m |
| Gross Profit | HK$19.42m |
| Other Expenses | HK$127.12m |
| Earnings | -HK$107.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.35 |
| Gross Margin | 27.95% |
| Net Profit Margin | -154.99% |
| Debt/Equity Ratio | 298.6% |
How did 8158 perform over the long term?
See historical performance and comparison